Research Articles Library
Literature Analysis Tools
Advanced Search
Filter by PMID, year, source, DOI and other criteria
Literature Analysis
Analyze research trends and hotspots
Batch Export
Export search results to Excel/PDF
Enhancement of gut barrier integrity by a Bacillus subtilis secreted metabolite through the GADD45A-Wnt/β-catenin pathway
Publication Year: 2025 Source: Imeta PMID: 40236773 DOI: 10.1002/imt2.70005
Inflammatory bowel disease (IBD) represents a significant challenge to global health, characterized by intestinal inflammation, impaired barrier function, and dysbiosis, with limited therapeutic options. In this study, we isolated a novel strain of Bacillus subtilis (B. subtilis) and observed promising effects in protecting against disruption of the gut barrier. Our …
Persistent Abdominal Pain and Diarrhea After Appendectomy-Crohn's Disease Versus Intestinal Tuberculosis
Publication Year: 2025 Source: JGH Open PMID: 40236937 DOI: 10.1002/jgh3.70157
CASE PRESENTATION: In Western Europe, intestinal tuberculosis is a rare differential diagnosis for Crohn's disease. In this report, we present a case of intestinal tuberculosis in a 59-year-old female initially suspected of Crohn's disease with persistent abdominal pain and diarrhea after appendectomy. CONCLUSION: This case highlights the need for TB …
Orally Administered Zn(x)Ce(y)O(2)/Se Hydrogel with Effective Antioxidant Activity for Treating Inflammatory Bowel Disease by Inhibiting Ferroptosis
Publication Year: 2025 Source: Adv Healthc Mater PMID: 40237090 DOI: 10.1002/adhm.202500088
Oxidative stress leads to intestinal barrier damage, which induces immune responses to occur and further promotes oxidative stress exacerbating inflammatory bowel disease (IBD). In this work, the multifunctional Zn(x)Ce(y)O(2)/Se (ZCSO) nanozyme wrapped with acid-resistant calcium alginate hydrogel designed for oral administration is prepared. The ZCSO nanozyme can promote the activation …
Global prevalence of biologic drugs use in inflammatory bowel diseases: a systematic review and meta-analysis
Publication Year: 2025 Source: Scand J Gastroenterol PMID: 40237230 DOI: 10.1080/00365521.2025.2491013
OBJECTIVES: Biologics are increasingly essential in managing inflammatory bowel diseases (IBDs) worldwide, as they can modify disease progression and improve patients' quality of life. This study aimed to analyze the global prevalence of and geographic variations in the use of biological drugs for IBD. MATERIALS AND METHODS: Articles published up …
Editorial: Defining Fecal Calprotectin Cutoffs That Predict Endoscopic and Histologic Remission Patients With Ulcerative Colitis
Publication Year: 2025 Source: Inflamm Bowel Dis PMID: 40237299
No Abstract
Inclusive Inflammatory Bowel Disease Care for Sexual and Gender Minorities: An Urgent Need in Uncertain Times
Publication Year: 2025 Source: Inflamm Bowel Dis PMID: 40237308
No Abstract
Disease Clearance in Ulcerative Colitis: A Narrative Review
Publication Year: 2025 Source: United European Gastroenterol J PMID: 40237360
Ulcerative colitis (UC) is a chronic relapsing disease with significant associated risks such as colectomy, hospitalization, or colorectal cancer. A treat-to-target approach that mitigates disease activity and progression from an early stage is needed. The latest STRIDE II guidelines advocate for clinical and endoscopic remission as the main therapeutic targets …
Early childhood antibiotics and chronic pediatric conditions: a retrospective cohort study
Publication Year: 2025 Source: J Infect Dis PMID: 40237450
BACKGROUND: Early-childhood antibiotic exposure has been implicated in the development of chronic pediatric conditions, but many studies leave concerns about unmeasured confounding. We evaluated associations between early-childhood antibiotic exposure and allergic, autoimmune, or neurodevelopmental/psychiatric conditions. METHODS: We performed a retrospective cohort study using electronic health records data from the United …
[The effect of inflammatory bowel diseases on the risk of atherosclerosis: assessment according to ultrasound imaging and sphygmometry]
Publication Year: 2025 Source: Ter Arkh PMID: 40237730 DOI: 10.26442/00403660.2025.01.203028
AIM: To evaluate the effect of inflammatory bowel disease (IBD) on the risk of atherosclerosis in patients without known cardiovascular disease. MATERIALS AND METHODS: The study included 115 patients divided into three groups: 37 patients with Crohn's disease (CD), 44 with ulcerative colitis (UC), and 34 in the control group …
[Effects of dynapenia and excess body weight in patients with ulcerative colitis]
Publication Year: 2025 Source: Ter Arkh PMID: 40237747
AIM: To evaluate the associated effects of dynapenia and overweight in patients with ulcerative colitis (UC). MATERIALS AND METHODS: Single-center observational cross-sectional case-control study. 80 patients with UC were divided into groups: 14 UC patients with dinapenia and overweight/obesity; UC and dinapenia patients with normal body weight/body weight deficiency (n=12); …
Need more literature?
The current database contains 98453 research articles. If you need to search for more literature or perform AI analysis, please use our knowledge acquisition module or explore external literature resources.
External Resources: Access comprehensive literature databases worldwide